The Interaction of the Endocannabinoid Anandamide and Paracannabinoid Lysophosphatidylinositol during Cell Death Induction in Human Breast Cancer Cells
International Journal of Molecular Sciences · 2024
DOI: 10.3390/ijms25042271 ↗Kurz gefasst
Fachartikel in der Zeitschrift International Journal of Molecular Sciences, 2024. Verfasst von Mikhail G Akimov und 8 weiteren Autor:innen. Beteiligte Einrichtung: Shemyakin-Ovchinnikov Institute of Bioorganic Chemistry, Russian Academy of Sciences, Miklukho-Maklaya 16/10, 117997 Moscow, Russia. Hauptthemen laut MEDLINE: Endocannabinoids, Breast Neoplasms, Arachidonic Acids, Lysophospholipids. Die Arbeit wurde bisher 5-mal zitiert (Crossref) und nennt 54 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Russian Science Foundation, Russian Scientific Foundation.
Abstract (Originalsprache)
Endocannabinoid anandamide (AEA) and paracannabinoid lysophosphatidylinositol (LPI) play a significant role in cancer cell proliferation regulation. While anandamide inhibits the proliferation of cancer cells, LPI is known as a cancer stimulant. Despite the known endocannabinoid receptor crosstalk and simultaneous presence in the cancer microenvironment of both molecules, their combined activity has never been studied. We evaluated the effect of LPI on the AEA activity in six human breast cancer cell lines of different carcinogenicity (MCF-10A, MCF-7, BT-474, BT-20, SK-BR-3, MDA-MB-231) using resazurin and LDH tests after a 72 h incubation. AEA exerted both anti-proliferative and cytotoxic activity with EC50 in the range from 31 to 80 µM. LPI did not significantly affect the cell viability. Depending on the cell line, the response to the LPI–AEA combination varied from a decrease in AEA cytotoxicity to an increase in it. Based on the inhibitor analysis of the endocannabinoid receptor panel, we showed that for the former effect, an active GPR18 receptor was required and for the latter, an active CB2 receptor. The data obtained for the first time are important for the understanding the manner by which endocannabinoid receptor ligands acting simultaneously can modulate cancer growth at different stages.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Shemyakin-Ovchinnikov Institute of Bioorganic Chemistry, Russian Academy of Sciences, Miklukho-Maklaya 16/10, 117997 Moscow, Russia.
ORCID-Profile: Mikhail G Akimov, Vladimir V Bezuglov
Förderung
- Russian Science Foundation
- Russian Scientific Foundation
Zitieren
APA
Akimov, M. G., Gretskaya, N. M., Gorbacheva, E. I., Khadour, N., Chernavskaya, V. S., Sherstyanykh, G. D., Kovaleko, T. F., Fomina-Ageeva, E. V., & Bezuglov, V. V. (2024). The Interaction of the Endocannabinoid Anandamide and Paracannabinoid Lysophosphatidylinositol during Cell Death Induction in Human Breast Cancer Cells. International Journal of Molecular Sciences. https://doi.org/10.3390/ijms25042271
Vancouver
Akimov MG, Gretskaya NM, Gorbacheva EI, Khadour N, Chernavskaya VS, Sherstyanykh GD, et al. The Interaction of the Endocannabinoid Anandamide and Paracannabinoid Lysophosphatidylinositol during Cell Death Induction in Human Breast Cancer Cells. International Journal of Molecular Sciences. 2024. doi:10.3390/ijms25042271
BibTeX
@article{Akimov2024,
author = {Akimov, Mikhail G and Gretskaya, Natalia M and Gorbacheva, Evgenia I and Khadour, Nisreen and Chernavskaya, Valeria S and Sherstyanykh, Galina D and Kovaleko, Tatiana F and Fomina-Ageeva, Elena V and Bezuglov, Vladimir V},
title = {The Interaction of the Endocannabinoid Anandamide and Paracannabinoid Lysophosphatidylinositol during Cell Death Induction in Human Breast Cancer Cells},
journal = {International Journal of Molecular Sciences},
year = {2024},
doi = {10.3390/ijms25042271}
}
EUVIMED